LONDON, UK - Imperial College-based biotech startup Baseimmune has secured $4.8m funding to develop the next generation of future-proof universal vaccines against major human and animal diseases.   Around 1.5 million people die every year around the world due to a lack of effective vaccines.* There is an urgent need to develop better universal vaccines against existing diseases, including, COVID, flu and malaria, as well as future-proof vaccines that can cope with the emergence of...
Source: RealWire
- View Press Release
|
|
|
